Screener
Cytokinetics CYTK Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $11.57B.
The source filing: Cytokinetics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338217
FAQ
- What is Cytokinetics's market capitalization?
- Cytokinetics (CYTK) reported market capitalization of $11.57B in Q2 2026.
- How has Cytokinetics's market capitalization changed year-over-year?
- Cytokinetics's market capitalization increased by 190.0% year-over-year, from $3.99B to $11.57B.
- What is the long-term trend for Cytokinetics's market capitalization?
- Over 5 years (2020 to 2025), Cytokinetics's market capitalization has grown at a 34.7% compound annual growth rate (CAGR), from $1.75B to $7.77B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Cytokinetics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude